Dhiab, R. Ben
Loyaux, R.
Garinet, S.
Bastide, M.
Léonard-Goyet, S.
Fabre, Elizabeth
Mansuet-Lupo, Audrey
Gibault, Laure
Jouveshomme, S.
Giroux-Leprieur, E.
Leroy, K.
Wislez, M.
Blons, H.
Article History
Received: 3 June 2024
Accepted: 21 April 2025
First Online: 2 June 2025
Declarations
:
: M.W. consulting fees from MSD, BMS, Astra Zeneca, Janssen, Sanofi, H.B. consulting fees from MSD, Astra Zeneca, Janssen, Takeda, Amgen; the other authors state that there are no conflicts of interest to disclose.
: Informed consent was obtained from all subjects involved in the study.
: The project was approved by the local ethic committee (REF2021-09-10 CERAPHP Centre).